Rosuvastatin in Older Patients with Systolic Heart Failure - The New England Journal of Medicine - 2007
Brief Summary:
Low dose rosuvastatin does not improve survival among patients with moderate-severe ischemic cardiomyopathy, but may reduce the rate of cardiovascular hospitalizations.Reference: http://www.ncbi.nlm.nih.gov/pubmed/17984166
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you